Skip to main content
. 2023 Apr 19;115(7):822–830. doi: 10.1093/jnci/djad069

Table 1.

Age adjusted malignant cancer death rate by race and ethnicity in the United States, aged 20 years or older from 2018 to 2020

Cancer type Overall Men Rate ratio (95% CI)a Women Rate ratio (95% CI)b 20-49 years 50-69 years ≥70 years
American Indian/Alaska Native individuals
 All cancers 214.9 249.2 0.99 (0.96 to 1.03) 189.9 1.04 (1.00 to 1.08)c 28.7 279.6 968.6
 Oral cavity and pharynx 2.9 4.3 0.75 (0.57 to 0.97)c 1.7 0.79 (0.53 to 1.15) 5.6 8.4
 Esophagus 5.1 8.1 0.77 (0.62 to 0.93)c 2.6 1.26 (0.92 to 1.69) 8.1 20.9
 Stomach 7.8 10.7 2.68 (2.23 to 3.19)c 5.6 2.78 (2.23 to 3.42)c 2.1 9.8 30.8
 Colorectum 23.5 27.9 1.30 (1.17 to 1.45)c 19.8 1.30 (1.16 to 1.46)c 4.9 30.7 97.0
 Liver 17.6 24.8 2.10 (1.88 to 2.34)c 12.0 2.33 (2.02 to 2.68)c 1.0 32.2 67.3
 Pancreas 14.4 16.1 0.88 (0.76 to 1.01) 12.9 0.95 (0.83 to 1.09) 1.4 20.4 63.7
 Lung 45.2 50.1 0.84 (0.77 to 0.91)c 41.5 0.94 (0.87 to 1.01) 1.9 57.9 225.6
 Soft tissue including heart 1.4 1.6 0.77 (0.47 to 1.19) 1.3 0.87 (0.53 to 1.34) 0.6 1.8 4.8
 Breast 24.8 24.8 0.91 (0.82 to 1.00) 6.9 31.3 97.1
 Cervix 4.1 4.1 1.43 (1.10 to 1.82)c 2.8 7.3
 Uterus 6.5 6.5 1.00 (0.82 to 1.21) 1.3 9.7 25.2
 Ovary 8.3 8.3 0.92 (0.77 to 1.09) 2.1 10.6 33.2
 Prostate 25.4 25.4 1.02 (0.90 to 1.16) 14.8 164.3
 Bladder 3.3 4.7 0.43 (0.32 to 0.57)c 2.2 0.74 (0.51 to 1.03) 2.9 18.9
 Kidney 9.2 13.2 1.79 (1.52 to 2.08)c 5.9 1.92 (1.55 to 2.35)c 1.1 12.7 40.3
 CNS 3.5 3.8 0.45 (0.33 to 0.59)c 3.2 0.59 (0.44 to 0.77)c 1.4 5.0 10.2
 Non-Hodgkin lymphoma 6.4 8.6 0.88 (0.71 to 1.07) 4.8 0.85 (0.67 to 1.07) 0.7 7.3 31.8
 Myeloma 4.3 5.2 1.02 (0.78 to 1.30) 3.6 1.18 (0.89 to 1.53) 4.8 21.9
 Leukemia 6.3 8.1 0.70 (0.57 to 0.84)c 4.8 0.76 (0.60 to 0.95)c 1.5 5.7 30.4
Asian individuals
 All cancers 126.8 147.9 0.59 (0.58 to 0.60)c 111.4 0.61 (0.60 to 0.62)c 15.9 146.7 613.0
 Oral cavity and pharynx 2.8 4.3 0.74 (0.69 to 0.80)c 1.6 0.75 (0.68 to 0.84)c 0.6 4.3 10.3
 Esophagus 2.1 3.5 0.33 (0.31 to 0.36)c 1.0 0.45 (0.39 to 0.52)c 0.2 2.8 9.4
 Stomach 6.0 7.6 1.90 (1.79 to 2.01)c 4.8 2.36 (2.21 to 2.51)c 1.0 6.6 28.7
 Colorectum 12.5 15.0 0.70 (0.67 to 0.73)c 10.5 0.69 (0.66 to 0.72)c 2.1 15.3 55.9
 Liver 11.4 17.0 1.43 (1.38 to 1.49)c 7.0 1.36 (1.29 to 1.44)c 1.1 14.7 53.6
 Pancreas 10.5 11.4 0.62 (0.59 to 0.65)c 9.7 0.71 (0.68 to 0.75)c 0.7 11.0 55.6
 Lung 26.1 33.5 0.56 (0.55 to 0.58)c 20.6 0.47 (0.45 to 0.48)c 1.6 27.9 139.0
 Soft tissue including heart 1.2 1.4 0.66 (0.58 to 0.74)c 1.1 0.73 (0.64 to 0.83)c 0.5 1.5 4.2
 Breast 15.9 15.9 0.58 (0.56 to 0.60)c 4.5 25.1 51.5
 Cervix 2.1 2.1 0.73 (0.67 to 0.80)c 0.8 3.5 5.3
 Uterus 4.6 4.6 0.70 (0.66 to 0.75)c 0.7 7.7 17.1
 Ovary 6.0 6.0 0.66 (0.63 to 0.70)c 1.2 10.7 19.0
 Prostate 11.6 11.6 0.47 (0.44 to 0.49)c 5.3 78.5
 Bladder 2.3 3.9 0.36 (0.33 to 0.38)c 1.2 0.39 (0.34 to 0.44)c 0.1 1.3 15.0
 Kidney 2.1 3.1 0.42 (0.39 to 0.46)c 1.3 0.44 (0.39 to 0.49)c 0.2 2.4 10.7
 CNS 3.0 3.9 0.46 (0.43 to 0.50)c 2.3 0.43 (0.39 to 0.47)c 1.0 4.4 10.3
 Non-Hodgkin lymphoma 4.9 6.4 0.66 (0.62 to 0.70)c 3.7 0.67 (0.63 to 0.72)c 0.4 4.7 26.7
 Myeloma 2.0 2.6 0.49 (0.45 to 0.54)c 1.6 0.54 (0.48 to 0.60)c 0.1 1.9 11.7
 Leukemia 4.4 5.9 0.50 (0.47 to 0.54)c 3.3 0.52 (0.48 to 0.55)c 0.7 4.1 22.3
Black individuals
 All cancers 241.5 298.2 1.19 (1.18 to 1.20)c 206.5 1.13 (1.12 to 1.14)c 30.2 327.8 1070.8
 Oral cavity and pharynx 3.5 6.0 1.04 (1.00 to 1.09) 1.7 0.80 (0.74 to 0.86)c 0.5 6.4 11.7
 Esophagus 4.0 6.5 0.61 (0.59 to 0.64)c 2.1 1.02 (0.96 to 1.09) 0.4 7.2 14.5
 Stomach 6.9 9.8 2.46 (2.36 to 2.56)c 4.9 2.40 (2.28 to 2.51)c 1.0 8.3 31.8
 Colorectum 24.1 30.8 1.44 (1.41 to 1.47)c 19.4 1.28 (1.25 to 1.31)c 4.1 33.3 100.5
 Liver 11.4 17.9 1.51 (1.47 to 1.55)c 6.6 1.28 (1.23 to 1.33)c 1.0 21.9 39.7
 Pancreas 19.3 21.8 1.19 (1.16 to 1.22)c 17.4 1.28 (1.25 to 1.31)c 1.5 27.3 87.7
 Lung 50.2 68.7 1.15 (1.13 to 1.17)c 37.6 0.85 (0.84 to 0.86)c 2.5 70.5 235.7
 Soft tissue including heart 2.1 2.1 1.02 (0.94 to 1.11) 2.0 1.37 (1.28 to 1.47)c 0.9 2.9 6.1
 Breast 38.7 38.7 1.41 (1.39 to 1.44)c 12.1 58.7 125.3
 Cervix 4.7 4.7 1.64 (1.56 to 1.72)c 2.4 7.0 10.8
 Uterus 13.1 13.1 2.00 (1.95 to 2.06)c 1.1 21.7 52.4
 Ovary 8.0 8.0 0.88 (0.85 to 0.91)c 1.1 12.9 30.5
 Prostate 52.6 52.6 2.12 (2.08 to 2.16)c 0.5 38.2 328.6
 Bladder 4.7 7.3 0.66 (0.63 to 0.69)c 3.1 1.02 (0.96 to 1.08) 0.2 4.2 26.8
 Kidney 4.6 7.1 0.96 (0.92 to 1.00)c 2.9 0.94 (0.89 to 0.99)c 0.7 6.1 20.1
 CNS 3.8 4.7 0.55 (0.52 to 0.58)c 3.1 0.57 (0.54 to 0.60)c 1.2 5.6 12.4
 Non-Hodgkin lymphoma 5.3 7.0 0.72 (0.69 to 0.75)c 4.1 0.74 (0.70 to 0.77)c 1.1 6.4 23.4
 Myeloma 8.2 10.2 1.97 (1.89 to 2.05)c 6.9 2.27 (2.18 to 2.36)c 0.5 8.7 43.7
 Leukemia 7.1 9.3 0.80 (0.77 to 0.83)c 5.7 0.89 (0.86 to 0.93)c 1.5 7.6 33.1
Latino individuals
 All cancers 148.5 177.2 0.71 (0.70 to 0.71)c 128.4 0.70 (0.70 to 0.71)c 18.9 172.6 715.0
 Oral cavity and pharynx 2.0 3.2 0.56 (0.52 to 0.59)c 1.1 0.52 (0.47 to 0.57)c 0.3 2.8 9.1
 Esophagus 2.7 4.9 0.46 (0.44 to 0.48)c 0.9 0.43 (0.39 to 0.48)c 0.3 3.7 11.9
 Stomach 6.5 8.1 2.03 (1.95 to 2.12)c 5.4 2.65 (2.53 to 2.77)c 1.6 7.9 27.1
 Colorectum 14.8 18.7 0.87 (0.85 to 0.90)c 11.7 0.77 (0.75 to 0.79)c 2.4 18.5 66.5
 Liver 12.7 18.0 1.52 (1.48 to 1.56)c 8.4 1.64 (1.58 to 1.70)c 0.7 19.4 56.4
 Pancreas 12.4 13.6 0.74 (0.72 to 0.76)c 11.3 0.84 (0.81 to 0.86)c 0.8 15.0 62.2
 Lung 20.8 28.0 0.47 (0.46 to 0.48)c 15.5 0.35 (0.34 to 0.36)c 0.9 20.7 115.4
 Soft tissue including heart 1.5 1.6 0.77 (0.71 to 0.84)c 1.4 0.92 (0.85 to 1.00)c 0.6 2.0 4.4
 Breast 19.0 19.0 0.69 (0.68 to 0.71)c 5.1 28.4 66.2
 Cervix 3.4 3.4 1.19 (1.12 to 1.25)c 2.0 4.8 7.2
 Uterus 6.0 6.0 0.92 (0.88 to 0.96)c 0.9 9.5 23.0
 Ovary 6.7 6.7 0.74 (0.71 to 0.76)c 1.2 10.5 24.7
 Prostate 20.9 20.9 0.84 (0.82 to 0.87)c 0.1 10.8 139.8
 Bladder 3.2 5.3 0.48 (0.46 to 0.51)c 1.7 0.57 (0.53 to 0.61)c 0.1 2.1 20.0
 Kidney 4.5 6.5 0.87 (0.84 to 0.91)c 2.9 0.93 (0.87 to 0.98)c 0.5 5.6 21.0
 CNS 4.1 4.8 0.57 (0.54 to 0.59)c 3.6 0.66 (0.62 to 0.69)c 1.1 5.7 15.4
 Non-Hodgkin lymphoma 6.1 7.8 0.81 (0.77 to 0.84)c 4.8 0.86 (0.82 to 0.90)c 0.6 5.7 33.0
 Myeloma 3.6 4.3 0.84 (0.79 to 0.89)c 3.0 0.98 (0.92 to 1.04) 0.2 3.7 19.4
 Leukemia 5.6 7.0 0.60 (0.58 to 0.63)c 4.5 0.70 (0.67 to 0.74)c 1.4 4.8 26.7
Native Hawaiian and Pacific Islander individuals
 All cancers 197.3 205.6 0.82 (0.77 to 0.87)c 192.1 1.05 (0.99 to 1.11) 43.7 288.4 743.1
 Oral cavity and pharynx 3.7 4.7 0.82 (0.55 to 1.18) 2.8 1.32 (0.74 to 2.15) 1.7 7.4
 Esophagus 2.8 4.5 0.42 (0.27 to 0.62)c 4.9 9.6
 Stomach 8.7 11.2 2.81 (2.09 to 3.70)c 6.7 3.32 (2.34 to 4.55)c 2.3 10.4 35.8
 Colorectum 14.6 16.6 0.77 (0.62 to 0.95)c 12.6 0.83 (0.65 to 1.04) 5.4 24.4 38.7
 Liver 15.1 21.6 1.83 (1.51 to 2.20)c 9.0 1.76 (1.30 to 2.32)c 4.8 24.7 45.1
 Pancreas 12.2 11.8 0.64 (0.49 to 0.84)c 12.5 0.92 (0.71 to 1.17) 1.6 17.5 51.5
 Lung 38.5 47.5 0.80 (0.69 to 0.91)c 30.7 0.69 (0.59 to 0.81)c 3.2 53.5 175.8
 Soft tissue including heart 2.7 1.9 0.90 (0.46 to 1.61) 3.3 2.23 (1.36 to 3.46)c 5.4
 Breast 33.2 33.2 1.21 (1.05 to 1.39)c 8.2 61.0 95.8
 Cervix 6.9 6.9 2.43 (1.75 to 3.30)c 4.4 8.7 15.5
 Uterus 19.5 19.5 2.99 (2.47 to 3.58)c 9.4 34.1 38.0
 Ovary 7.8 7.8 0.86 (0.63 to 1.16) 13.3 22.0
 Prostate 23.0 23.0 0.92 (0.74 to 1.13) 16.4 143.6
 Bladder 4.0 6.2 0.57 (0.36 to 0.84)c 2.1 0.71 (0.36 to 1.26) 24.0
 Kidney 3.7 5.5 0.74 (0.49 to 1.08) 2.1 0.68 (0.35 to 1.18) 5.9 13.9
 CNS 3.8 3.9 0.46 (0.27 to 0.72)c 3.7 0.69 (0.43 to 1.04) 5.3 12.5
 Non-Hodgkin lymphoma 6.8 7.2 0.74 (0.52 to 1.04) 6.4 1.15 (0.79 to 1.61) 1.5 7.9 29.8
 Myeloma 3.8 4.4 0.86 (0.52 to 1.32) 3.4 1.12 (0.66 to 1.77) 4.9 19.2
 Leukemia 7.9 9.5 0.81 (0.59 to 1.09) 6.5 1.02 (0.71 to 1.42) 2.3 8.8 32.4
White individuals
 All cancers 212.3 250.8 183.0 23.5 255.7 1020.3
 Oral cavity and pharynx 3.8 5.8 2.1 0.5 6.3 14.7
 Esophagus 6.0 10.6 2.1 0.6 9.4 25.0
 Stomach 2.9 4.0 2.0 0.5 3.6 12.9
 Colorectum 18.1 21.4 15.2 3.2 22.4 80.2
 Liver 8.2 11.8 5.1 0.6 13.2 34.3
 Pancreas 15.8 18.4 13.6 1.2 20.1 76.7
 Lung 51.1 59.7 44.3 2.4 66.6 251.3
 Soft tissue including heart 1.8 2.1 1.5 0.6 2.2 6.5
 Breast 27.4 27.4 6.5 37.2 106.7
 Cervix 2.9 2.9 1.9 4.2 4.6
 Uterus 6.5 6.5 0.7 9.4 28.4
 Ovary 9.0 9.0 1.4 12.9 37.4
 Prostate 24.8 24.8 0.2 12.8 165.8
 Bladder 6.4 10.9 3.0 0.2 4.6 39.2
 Kidney 5.1 7.4 3.1 0.5 6.3 24.2
 CNS 6.9 8.5 5.4 2.2 10.4 22.0
 Non-Hodgkin lymphoma 7.4 9.7 5.6 0.6 6.1 42.3
 Myeloma 4.0 5.2 3.1 0.2 3.6 22.8
 Leukemia 8.7 11.7 6.3 1.1 6.8 48.3
a

Rate ratios compare to White men. “—” signifies statistic not displayed because of fewer than 10 cases or not applicable. CI = confidence Interval; CNS = central nervous system.

b

Rate ratios compared to White women.

c

Denotes statistical significance (P < .05).